BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9310479)

  • 1. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
    Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
    Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
    Petzer AL; Zandstra PW; Piret JM; Eaves CJ
    J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
    Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
    J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
    Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
    Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
    Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.
    Ramsfjell V; Borge OJ; Veiby OP; Cardier J; Murphy MJ; Lyman SD; Lok S; Jacobsen SE
    Blood; 1996 Dec; 88(12):4481-92. PubMed ID: 8977240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.
    Sawai N; Koike K; Ito S; Mwamtemi HH; Kurokawa Y; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Miyazaki H; Kato T; Komiyama A
    Blood; 1999 Jan; 93(2):509-18. PubMed ID: 9885212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
    Willems R; Henckaerts E; Lenjou M; Nijs G; Rodrigus I; Moulijn AC; Slegers H; Berneman ZN; Van Bockstaele DR
    Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
    Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
    Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
    Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand.
    Haylock DN; Horsfall MJ; Dowse TL; Ramshaw HS; Niutta S; Protopsaltis S; Peng L; Burrell C; Rappold I; Buhring HJ; Simmons PJ
    Blood; 1997 Sep; 90(6):2260-72. PubMed ID: 9310477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
    Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
    Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.